The Arizona legal cannabis market size is projected to reach USD 3.32 billion by 2030, registering a CAGR of 14.4% from 2023 to 2030, according to a new report by Grand View Research, Inc. It is driven by increasing government support for legalization and growing awareness of its benefits. Additionally, a study published by The Good Body in 2022 has shown that around 40% of the U.S. population experiences chronic pain lasting 3 to 6 months, even after medication. Moreover, according to a study published by the NCBI, two-thirds of patients with chronic pain conditions such as arthritis, neuropathic pain, and post-surgical pain have reported pain relief with medical marijuana. These factors are expected to drive the demand for pain management therapies and contribute to market growth over the forecast period.
In 1996, the Drug Medicalization, Prevention, and Control Act was passed in Arizona after receiving 65% votes. The act allowed healthcare professionals to prescribe cannabis for patients suffering from terminal illnesses. Furthermore, in 2020, Proposition 207 was approved by voters in Arizona which legalized the possession, use, and cultivation of cannabis for recreational use among adults over the age of 21. The Arizona Department of Health Services is responsible for regulating and overseeing the state's medical marijuana program and is responsible for issuing medical marijuana cards to patients for the legal purchase of cannabis products.
Key players in the market, such as Nature’s Medicines, 4Front, Item 9 Labs, Harvest Health and Recreation, PathogenDx, Cannabox, Copperstate Farms, and Sunday Goods are adopting strategies such as acquisitions, partnerships, expansions, collaborations, and new product launches to strengthen their market position and expand their customer base. For instance, in May 2022, Nature’s Medicines announced the establishment of a new dispensary in Massachusetts. The new establishment is equipped with advanced facilities such as open conference spaces for enhanced shopping and educational experiences. Moreover, in May 2022, Nature’s Medicines partnered with Cheech Marin & Tommy Chong for the launch of two cannabis product lines, Tommy Chong's and Cheech & Chong's. These products contain prepacked flowers and are available for purchase in New Mexico and Arizona.
Request a free sample copy or view report summary: Arizona Legal Cannabis Market Report
Grand View Research has segmented the Arizona legal cannabis market report based on source, product type, cultivation and end-use:
Arizona Legal Cannabis Source Outlook (Revenue, USD Million, 2018 - 2030)
Hemp
Hemp CBD
Industrial Hemp
Marijuana
Flower
Oil and Tinctures
Arizona Legal Cannabis Derivatives Outlook (Revenue, USD Million, 2018 - 2030)
CBD
Others
Arizona Legal Cannabis Cultivation Outlook (Revenue, USD Million, 2018 - 2030)
Indoor Cultivation
Greenhouse Cultivation
Outdoor Cultivation
Arizona Legal Cannabis End-use Outlook (Revenue, USD Million, 2018 - 2030)
Industrial Use
Medical Use
Chronic Pain
Depression and Anxiety
Arthritis
Post-traumatic Stress Disorder (PTSD)
Cancer
Migraines
Epilepsy
Alzheimer’s
Multiple Sclerosis
AIDS
Amyotrophic Lateral Sclerosis
Tourette’s
Diabetes
Parkinson's
Glaucoma
Others
"The quality of research they have done for us has been excellent..."